Mapping the hidden toll: how breast cancer brain metastases affect daily life

NCT ID NCT07659652

Not yet recruiting Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 200 adults with stage 4 breast cancer that has spread to the brain or spinal lining. Participants fill out questionnaires about their symptoms, thinking abilities, and physical function over time. The goal is to track how symptoms change and how treatments affect quality of life, helping guide future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help doctors better understand and manage symptoms, improving care decisions for patients with breast cancer that has spread to the brain.
What could go wrong: This is an observational study, not a treatment trial, so it will not directly test a new therapy. Results depend on patient-reported data, which can vary widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN METASTASES FROM BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Neoplasm Metastasis neoplastic meningitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN METASTASES FROM BREAST CANCER BREAST CANCER, METASTATIC BREAST CANCER, METASTATIC BREAST CANCER BREAST CANCER, QUALITY OF LIFE LEPTOMENINGEAL METASTASIS OF BREAST CANCER

Contacts and locations

Show contact details

Locations

University of California, San Francisco

San Francisco, California, 94143, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.